People instinctively mimic others’ facial expressions, but new research shows we do this far more with joyful faces than with sadness or anger—and that the intensity of mimicry predicts how much we ...
DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...
The combination of trabectedin (Yondelis; Pharma Mar, Johnson & Johnson) and olaparib (Lynparza; AstraZeneca, Merck) may be a meaningful treatment for certain patients with advanced soft tissue ...
L’égalité entre les femmes et les hommes est désormais institutionnalisée. Mais lorsqu’elle cesse d’être un principe abstrait ...
Discover Magazine on MSN
Smiling Through the Holidays Can Instantly Change How People See You
Learn how smiling — and mimicking other people’s smiles — can make you seem more trustworthy and confident.
OP-ED. In an op-ed for Le Monde, researchers Stefania Di Stefano and Garance Denner argue that American accusations of ...
"Today’s procurement formalizes efforts to partner with private investors and developers," Authority CEO Ian Choudri said.
Daiichi Sankyo &AstraZeneca’s Enhertu approved in China as first HER2 directed medicine for patients with HER2 low or HER2 ultralow metastatic breast cancer ...
If you need a reason to care about DEI in higher education, this is it: Indoctrinated students are now counseling your ...
The exhibition for the winning entries of the 6th China animal specimen competition opened in Shanghai on Saturday.
At the British School of Bucharest (BSB), learning extends beyond desks, textbooks and examinations into a broader ...
NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback